Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)

TPE:6919 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,573	6,901	3,422	655.05	594.91	93.56
Short-Term Investments	1,826	2,767	289.4	456.18	-	-
Cash & Short-Term Investments	9,400	9,669	3,712	1,111	594.91	93.56
Cash Growth	181.44%	160.51%	234.01%	86.79%	535.87%	331.36%
Accounts Receivable	0.21	5.18	7.89	3.12	-	-
Receivables	0.21	5.18	7.89	3.12	-	-
Inventory	7.31	2.86	1.02	2.81	0.05	2.53
Other Current Assets	36.19	29.12	23.16	14.87	10.32	14.96
Total Current Assets	9,443	9,706	3,744	1,132	605.27	111.05
Property, Plant & Equipment	53.67	61.32	80.41	99.6	106.38	114.68
Other Intangible Assets	-	-	-	-	-	0.07
Other Long-Term Assets	2.93	3.14	2.46	1.46	1.26	1.26
Total Assets	9,500	9,771	3,827	1,233	712.9	227.05
Accounts Payable	0.01	0.97	1.7	2.53	0.33	0.74
Accrued Expenses	25.97	1.97	-	-	30.98	45.14
Current Portion of Long-Term Debt	-	-	-	-	1.17	7.97
Current Portion of Leases	7.46	8.88	8.58	8.22	7.03	6.79
Current Unearned Revenue	7.7	3.61	1.03	4.5	-	-
Other Current Liabilities	38.88	37.32	62.37	33.11	0.16	3.82
Total Current Liabilities	80.01	52.74	73.68	48.36	39.67	64.45
Long-Term Debt	-	-	-	-	3.55	83.95
Long-Term Leases	-	3	11.87	20.46	25.02	32.06
Other Long-Term Liabilities	23.29	17.71	-	-	-	-
Total Liabilities	103.59	73.7	85.55	68.82	68.24	180.46
Common Stock	775.51	769.14	696.62	615.55	535.93	312.17
Additional Paid-In Capital	9,250	9,131	3,271	834.46	217.47	106.85
Retained Earnings	-248.81	-56.14	-227.31	-286.16	-107.41	-371.05
Treasury Stock	-	-	-0.07	-0.08	-0.09	-
Comprehensive Income & Other	-380.06	-147.47	0.81	0.49	-1.24	-1.38
Shareholders' Equity	9,396	9,697	3,741	1,164	644.66	46.6
Total Liabilities & Equity	9,500	9,771	3,827	1,233	712.9	227.05
Total Debt	7.46	11.87	20.46	28.68	36.78	130.76
Net Cash (Debt)	9,392	9,657	3,691	1,083	558.13	-37.2
Net Cash Growth	182.59%	161.63%	240.96%	93.96%	-	-
Net Cash Per Share	6.25	6.75	2.98	0.92	0.61	-0.05
Filing Date Shares Outstanding	1,551	1,538	1,393	1,231	1,072	832.92
Total Common Shares Outstanding	1,551	1,538	1,393	1,231	1,072	832.92
Working Capital	9,363	9,653	3,670	1,084	565.6	46.6
Book Value Per Share	6.06	6.30	2.69	0.95	0.60	0.06
Tangible Book Value	9,396	9,697	3,741	1,164	644.66	46.53
Tangible Book Value Per Share	6.06	6.30	2.69	0.95	0.60	0.06
Machinery	137.86	138.75	129.99	121.55	112.76	76.42
Construction In Progress	4.8	-	1.14	1.82	0.3	31.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.